Skip to content

Additive vs Subtractive Manufacturing for Endocrown Fabrication: A 24-Month RCT

Additive Versus Subtractive Manufacturing for Endocrown Fabrication: A Clinical Comparison of 3D-Printed Ceramic-Filled Photopolymer Resin and CAD/CAM Milled Resin Nano-Ceramics Endocrowns in Posterior Teeth - A 24-Month Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07633574
Acronym
ENDO-3D
Enrollment
60
Registered
2026-06-08
Start date
2026-06-01
Completion date
2028-09-01
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Restoration, Endodontically Treated Teeth, Tooth, Nonvital

Brief summary

This randomized controlled trial (RCT) compares the 24-month clinical performance of endocrown restorations fabricated by two digital manufacturing pathways: additive manufacturing using 3D-printed ceramic-filled photopolymer resin (VarseoSmile TriniQ, BEGO) versus subtractive computer-aided design/computer-aided manufacturing (CAD/CAM) milling from hybrid nano-ceramic blocks (HC Hard Block, Shofu). Sixty endocrowns will be placed in endodontically treated posterior molars and evaluated using modified United States Public Health Service (USPHS) criteria at 6, 12, and 24 months. The trial is conducted at the Conservative Dentistry Department, Faculty of Dentistry, Cairo University.

Detailed description

Post-endodontic rehabilitation of extensively damaged posterior molars using endocrowns represents a minimally invasive alternative to conventional crown-plus-post-and-core approaches. Digital fabrication has advanced both the precision and reproducibility of endocrown manufacture. While computer-aided design/computer-aided manufacturing (CAD/CAM) milled hybrid ceramic endocrowns are well-validated clinically, prospective clinical data comparing 3D-printed definitive restorations to milled counterparts are absent. This trial employs a parallel-group, 1:1 randomized design with triple blinding of participants, outcome assessors, and statistician. All restorations are delivered using Beautilink SA self-adhesive dual-cure resin cement. The primary outcome is fracture resistance at 24 months; secondary outcomes include retention, marginal adaptation, marginal discoloration, surface texture, anatomic form, color match, secondary caries, fabrication time, and patient satisfaction assessed by Visual Analogue Scale (VAS).

Interventions

DEVICECAD/CAM Milled HC Hard Block Endocrown

Endocrown restoration milled from HC Hard Block hybrid nano-ceramic (Shofu Inc., Japan) using a five-axis wet-milling CAD/CAM unit. Restoration designed with ExoCAD software, finished and glazed per manufacturer protocol, and cemented with Beautilink SA self-adhesive dual-cure resin cement (Shofu Inc., Japan).

DEVICE3D-Printed VarseoSmile TriniQ Endocrown

Endocrown restoration 3D-printed using VarseoSmile TriniQ ceramic-filled photopolymer resin (BEGO GmbH \& Co. KG, Germany) on a 4K LCD printer at 30-45 degree build angle. Post-cured under nitrogen atmosphere, surface glazed, and cemented with Beautilink SA self-adhesive dual-cure resin cement (Shofu Inc., Japan).

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The treating clinician cannot be blinded due to visible differences between manufacturing workflows. Participants and outcome assessors are blinded to group allocation. The trial statistician is blinded to group assignment throughout analysis.

Eligibility

Sex/Gender
ALL
Age
25 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Age 25-45 years, male or female * Endodontically treated molar tooth with radiographically confirmed treatment success and no clinical signs of failure * Sufficient remaining coronal structure for endocrown preparation: minimum three walls, wall thickness 1.5 mm or greater, pulp chamber depth 3 mm or greater, supragingival preparation margins * Completely erupted tooth with intact periodontal support * Minimum of 20 occluding teeth * Satisfactory oral hygiene status * Capable of providing written informed consent and committed to scheduled follow-up visits

Exclusion criteria

* Diagnosed parafunctional habit or nocturnal bruxism * Uncontrolled systemic illness or physical disability precluding safe participation * Heavy tobacco use * Current or suspected pregnancy * Periapical disease or radiographic signs of endodontic failure * Evidence of pathological tooth wear or occlusal erosion * Moderate-to-severe periodontitis or tooth with hopeless prognosis * Radiographic or clinical evidence of vertical root fracture * Impaired decision-making capacity or anticipated non-compliance

Design outcomes

Primary

MeasureTime frameDescription
Restoration Fracture Resistance24 monthsAssessed using modified USPHS criteria: Alpha = absence of fracture; Bravo = minor chip amenable to repair; Charlie = catastrophic fracture, unrestorable

Secondary

MeasureTime frameDescription
Retention6, 12, and 24 monthsModified USPHS: Alpha = in situ; Bravo = partial displacement; Charlie = complete loss
Marginal Discoloration6, 12, and 24 monthsModified USPHS: Alpha = absent; Bravo = superficial; Charlie = penetrating
Surface Texture6, 12, and 24 monthsModified USPHS: Alpha = smooth; Bravo = minor irregularities; Charlie = extensive breakdown
Anatomic Form6, 12, and 24 monthsModified USPHS: Alpha = conforms to natural contour; Bravo = discrepancy present, dentin intact; Charlie = dentin or base exposed
Color Match6, 12, and 24 monthsModified USPHS: Alpha = indistinguishable from adjacent tooth; Bravo = minor deviation, clinically acceptable; Charlie = obvious mismatch; Delta = gross color failure
Secondary Caries6, 12, and 24 monthsModified USPHS: Alpha = absent; Charlie = present
Fabrication TimePeriproceduralTime in minutes from CAD design completion to restoration readiness for cementation
Patient Satisfaction6, 12, and 24 monthsVisual Analogue Scale 0-100 mm; 0 = entirely dissatisfied, 100 = entirely satisfied

Contacts

CONTACTDina Ez Mohamed, BDS MSc PhD
dina.ezz@dentistry.cu.edu.eg01008007157
CONTACTRawda H Abdelaziz, BDS MSc PhD
rawda.hesham@dentistry.cu.edu.eg

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 9, 2026